Pharma Giles has a
fun new post up regarding Phoni's latest initiative. It involves corner cutting, placing research participants in danger, hyping products well beyond their actual utility, and executives getting filthy rich. You know, the kinds of things that could only happen at a fictional drug company such as Phoni. Check it out.
No comments:
Post a Comment